about
The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigueAlemtuzumab in the treatment of multiple sclerosis: patient selection and special considerationsEvidence of disease control: a realistic concept beyond NEDA in the treatment of multiple sclerosis.Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis.Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Alemtuzumab for multiple sclerosis
@ast
Alemtuzumab for multiple sclerosis
@en
Alemtuzumab for multiple sclerosis
@en-gb
Alemtuzumab for multiple sclerosis
@nl
type
label
Alemtuzumab for multiple sclerosis
@ast
Alemtuzumab for multiple sclerosis
@en
Alemtuzumab for multiple sclerosis
@en-gb
Alemtuzumab for multiple sclerosis
@nl
prefLabel
Alemtuzumab for multiple sclerosis
@ast
Alemtuzumab for multiple sclerosis
@en
Alemtuzumab for multiple sclerosis
@en-gb
Alemtuzumab for multiple sclerosis
@nl
P2093
P2860
P3181
P1476
Alemtuzumab for multiple sclerosis
@en
P2093
Gustavo J M Porfírio
Maria R Torloni
Rachel Riera
P2860
P304
P3181
P356
10.1002/14651858.CD011203.PUB2
P50
P577
2016-04-15T00:00:00Z